Bosera Hang Seng Health Care ETF(QDII) Stock (513060.SH) Real-time Quotes - Financial Data - Analyst Ratings

Company Encyclopedia

Bosera Hang Seng Health Care ETF(QDII)

513060.SH

Shareholder

Ownership	%Owned	Share Chg	Report Date
No Data

News

Innovent, first Chinese biotech firm to market weight-loss drug, joins Hang Seng Index

Innovent Biologics will join the Hang Seng Index next month, increasing the number of constituents to 89. The biotech firm recently signed an $11.4 billion deal with Takeda Pharmaceuticals. Innovent, China Hongqiao Group, and Yum China Holdings will also join the Hang Seng China Enterprises Index. The Hang Seng Index has risen nearly 30% this year. Innovent's stock has climbed 138.4% this year. ASMPT will be removed from the Hang Seng Tech Index, while ENN Energy Holdings, Haidilao International, and New Oriental Education & Technology Group will be deleted from the Hang Seng China Enterprises Index.

南华早报·1 Hours ago

Top 10 HK Stock Losers (11.21)

GANFENGLITHIUM(01772) fell 12.47%, with a trading turnover 2.1 Billion HKD, and a year-to-date rose 155.3%. CHONGQING M&E(02722) fell 12.32%, with a trading turnover 83.1 Million HKD, and a year-to-date rose 149.7%. CHINA NEXT-GEN(03928) fell 12.18%, with a trading turnover 6.0 Million HKD, and a year-to-date rose 295.2%.

LB Select·5 Hours ago

LB Select·5 Hours ago

BUZZ-3SBio drops most in seven months on unit spin-off plans

3SBio Inc's shares dropped 8.9% to HK$29.52, marking the largest decline since April, due to plans to spin off its 87.16%-owned unit, Mandi Inc, for a separate listing on the Hong Kong stock exchange. The Stock Exchange confirmed the spin-off, with 3SBio not retaining any interest in Mandi post-listing. Despite the drop, 3SBio's stock is up 400% YTD, while the Hang Seng Biotech Index rose 77%.

Reuters·7 Hours ago

3SBio spin-off Mandi banks on hair-loss and weight-loss drugs in Hong Kong IPO bid

Mandi, a consumer healthcare arm of 3SBio backed by Alibaba Health, filed for an IPO in Hong Kong, focusing on its minoxidil hair-loss products. The IPO aims to leverage Hong Kong's booming market, with plans to use the capital for product expansion and R&D. 3SBio will exit its stake in Mandi, which will raise funds through a global offering. Mandi's net profit rose 14.5% to 390.3 million yuan in 2024, and it is developing new drugs in phase III trials.

南华早报·8 Hours ago

Hong Kong corporate earnings week ahead

Diary of Hong Kong corporate earnings for the week ahead includes earnings releases from Chow Tai Fook Jewellery Group, Alibaba Group, Alibaba Health Information Technology, Li Auto, and Meituan. Dates range from November 25 to November 28, 2025. Specific times are listed as AMC, BMO, DBH, or NTS.

Reuters·10 Hours ago